MYOS RENS Shares Make Near-Term Parabolic Move, Spike Higher Then Sell Off As Traders Circulate Word Of New Buy Rating, $3.50 Target From Zack's; Shares Remain Up ~11% For Session; BZ NOTE: Zacks Is Not A Research Firm Which Normally Moves Stocks